Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1996;107:134–145.

At risk nephrons and the decline in renal function in response to treatment of hypertension.

W G Walker 1, C Ford 1
PMCID: PMC2376563  PMID: 8725567

Abstract

An examination of change in renal function following blood pressure lowering in more than 4,400 individuals in several clinical trials revealed that renal function declined following initiation of antihypertensive treatment in both essential hypertension and hypertensive diabetics for a period of two years before stabilizing at or near zero change. This initial decline can be related to the severity of preexisting hypertension but does not appear related to the type of antihypertensive regimen used. This phenomenon appears most readily explained by progressive obsolescence of previously damaged nephrons and not by the type of antihypertensive therapy employed. These finding raise questions about validity of interpretation of clinical trials designed to test efficacy of specific drug regimens in preserving renal function when outcome results are predominantly influenced by events during the first two years of intervention.

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakris G. L., Barnhill B. W., Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int. 1992 Apr;41(4):912–919. doi: 10.1038/ki.1992.139. [DOI] [PubMed] [Google Scholar]
  2. Bauer J. H., Reams G. P., Hewett J., Klachko D., Lau A., Messina C., Knaus V. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis. 1992 Nov;20(5):443–457. doi: 10.1016/s0272-6386(12)70256-1. [DOI] [PubMed] [Google Scholar]
  3. Björck S., Mulec H., Johnsen S. A., Nordén G., Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):339–343. doi: 10.1136/bmj.304.6823.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kasiske B. L., Kalil R. S., Ma J. Z., Liao M., Keane W. F. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993 Jan 15;118(2):129–138. doi: 10.7326/0003-4819-118-2-199301150-00009. [DOI] [PubMed] [Google Scholar]
  5. Levey A. S., Gassman J. J., Hall P. M., Walker W. G. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. J Am Soc Nephrol. 1991 Mar;1(9):1087–1094. doi: 10.1681/ASN.V191087. [DOI] [PubMed] [Google Scholar]
  6. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  7. Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Parving H. H., Andersen A. R., Smidt U. M., Hommel E., Mathiesen E. R., Svendsen P. A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1443–1447. doi: 10.1136/bmj.294.6585.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Slataper R., Vicknair N., Sadler R., Bakris G. L. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med. 1993 Apr 26;153(8):973–980. [PubMed] [Google Scholar]
  11. Walker W. G., Hermann J., Murphy R. P., Russell R. P. Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron. 1990;55 (Suppl 1):21–26. doi: 10.1159/000186030. [DOI] [PubMed] [Google Scholar]
  12. Walker W. G., Hermann J., Murphy R., Patz A. Elevated blood pressure and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy. Trans Am Clin Climatol Assoc. 1986;97:94–104. [PMC free article] [PubMed] [Google Scholar]
  13. Walker W. G., Hermann J., Yin D. P., Murphy R. P., Patz A. Diuretics accelerate diabetic nephropathy in hypertensive insulin-dependent and non-insulin-dependent subjects. Trans Assoc Am Physicians. 1987;100:305–315. [PubMed] [Google Scholar]
  14. Walker W. G. Hypertension-related renal injury: a major contributor to end-stage renal disease. Am J Kidney Dis. 1993 Jul;22(1):164–173. doi: 10.1016/s0272-6386(12)70183-x. [DOI] [PubMed] [Google Scholar]
  15. Walker W. G., Neaton J. D., Cutler J. A., Neuwirth R., Cohen J. D. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA. 1992 Dec 2;268(21):3085–3091. [PubMed] [Google Scholar]
  16. Wyndham R. N., Gimenez L., Walker W. G., Whelton P. K., Russell R. P. Influence of renin levels on the treatment of essential hypertension with thiazide diuretics. Arch Intern Med. 1987 Jun;147(6):1021–1025. [PubMed] [Google Scholar]
  17. Zatz R., Dunn B. R., Meyer T. W., Anderson S., Rennke H. G., Brenner B. M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986 Jun;77(6):1925–1930. doi: 10.1172/JCI112521. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES